Charles Schwab Investment Management »

Avalo Therapeutics Ord shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $149k 10k 14.93

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us L (FNDX)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Schwab Strategic Tr Fundamental Intl (FNDF)
Chevron Corporation (CVX)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Merck & Co (MRK)

View all positions for Charles Schwab Investment Management

Top funds holding Avalo Therapeutics Ord

FMR
Caligan Partners
BVF
venBio Select Advisor
Affinity Asset Advisors
Logos Global Management
Nantahala Capital Management
UBS Group
Caption Management
Point72 Asset Management
Farallon Capital Management
Rtw Investments
Adage Capital Partners GP
Millennium Management
TCG Crossover Management

View all funds holding Avalo Therapeutics Ord